ALPHA10X : de l’IA pour réduire le risque lié à l’investissement dans les sciences de la vie
Pharmacoprint: A Combination of a Pharmacophore Fingerprint and Artificial Intelligence as a Tool for Computer-Aided Drug Design
Federated learning for predicting clinical outcomes in patients with COVID-19
EU New Role as Tech Venture Capitalist
Accenture’s Julie Sweet: A.I. can transform companies, creating ‘responsibility and possibility’ for CEOs
The Bright New Age of Venture Capital
Artificial intelligence a key challenge for Germany's next government
Experts discuss barriers to deep tech ventures
Gates Foundation pours cash into British firm Exscientia to fight pandemics
Intelligence Artificielle : l'UM6P signe un partenariat avec la start-up ALPHA10X
ALPHA10X Emerges from Stealth With $9.4 Million In Seed Funding
3 Myths About Women Working in Tech, Busted
